New Zealand markets open in 2 hours 27 minutes
  • NZX 50

    12,282.42
    -106.42 (-0.86%)
     
  • NZD/USD

    0.7410
    +0.0069 (+0.93%)
     
  • ALL ORDS

    7,049.40
    -61.40 (-0.86%)
     
  • OIL

    63.04
    +1.37 (+2.22%)
     
  • GOLD

    1,797.50
    -8.40 (-0.47%)
     

Global Hair Loss Treatment Market to Surpass US$ 5,461.1 Million at a CAGR of 6.2% during 2020-2027, Says Coherent Market Insights (CMI)

·4-min read

According to Coherent Market Insights, the global hair loss treatment market is estimated to be valued at US$ 3,592.3 million in 2020 and is expected to exhibit a CAGR of 6.2% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Hair Loss Treatment Market:

Key trends in the market include rising incidence of hair loss and ongoing research and development on hair loss treatments.

Market players are focusing on research and development of cost effective and quality treatment for alopecia areata. For instance, Pfizer Inc., a multinational pharmaceutical company, initiated an interventional clinical trial for alopecia areata. The study was initiated to evaluate the efficacy and safety profile of PF-06651600 and PF-06700841 in subjects with alopecia areata. The Phase II trail was initiated in November 2016 and completed in May 2019.

However, side effects of hair loss treatment is expected to hinder the market growth. For instance, according to the Mayo Foundation for Medical Education and Research (MFMER), the leading topical agent such as minoxidil used in the treatment of alopecia exhibit side effects such as acne at site of application, burning of scalp, facial hair growth, hair loss, inflammation or soreness at the root of the hair, and others.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4374

Key Market Takeaways:

The global hair loss treatment market is expected to exhibit a CAGR of 6.2% during the forecast period, owing to the rising incidence of alopecia or hair loss across the globe. For instance, according to the American Hair Loss Association, by the age of 21, around 25% of men suffer pattern baldness in the U.S.

Key players in the market are focusing on drug development for the treatment of androgenetic alopecia, which is expected to propel the market growth during the forecast period. For instance, in January 2013, Dr. Reddy’s launched finasteride tablets, the generic version of Merck‘s Propecia. Propecia is indicated for treatment of male pattern hair in men only.

Competitive Landscape:

Key players operating in the global hair loss treatment market include Viviscal, Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy’s Laboratories, Ranbaxy Laboratories Ltd, HCell Inc., Follica, Inc., Aurobindo Pharma, and Zydus Pharmaceuticals, Inc. (Zydus Cadila) among others.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4374

Market Segmentation:

  • Global Hair Loss Treatment Market, By Type:

    • Noncicatricial

      • Telogen Effluvium

      • Androgenetic Alopecia

      • Alopecia Areata

    • Cicatricial

    • Others

  • Global Hair Loss Treatment Market, By Product Type:

    • Corticosteroids

    • Antihypertensives

    • Topical Immune-modulators

    • Others

  • Global Hair Loss Treatment Market, By Route of Administration:

    • Oral

    • Topical

  • Global Hair Loss Treatment Market, By Gender:

    • Male

    • Female

  • Global Hair Loss Treatment Market, By Distribution Channel:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Global Hair Loss Treatment Market, By Region:

    • North America

      • By Country:

        • U.S.

        • Canada

    • Latin America

      • By Country:

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • By Country:

        • Germany

        • U.K.

        • France

        • Italy

        • Spain

        • Russia

        • Rest of Europe

    • Asia Pacific

      • By Country:

        • China

        • India

        • Japan

        • Australia

        • South Korea

        • ASEAN

        • Rest of Asia Pacific

    • Middle East

      • By Country:

        • GCC

        • Israel

        • Rest of Middle East

    • Africa

      • By Country/Region:

        • South Africa

        • Central Africa

        • North Africa

Related Market Intelligence Reports:

Alopecia Treatment Market - Global Forecast to 2026, by Disease Type (Androgenic Alopecia, Alopecia Areata, and Others), by Drug Type (Topical Agents, 5 AR Inhibitors, Corticosteroids, and Others), by Gender (Male and Female), by Route of Administration (Oral, Topical, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026

Read more: https://www.coherentmarketinsights.com/market-insight/alopecia-treatment-market-1847

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210118005233/en/

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter